Fibromyalgia trial reports similar symptom improvements with Ba-Duan-Jin and pregabalin
In people with fibromyalgia, Ba-Duan-Jin and pregabalin groups both improved across several symptoms. Sleep improvement favoured pregabalin early on, and the abstract does not provide enough detail to verify equivalence.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Both groups improved in pain, fatigue, sleep and depression, with broadly similar results reported. Ba-Duan-Jin produced less sleep improvement than pregabalin at an early assessment. Pain and quality-of-life improvements persisted into later follow-up. Exploratory brain-imaging findings were associations in the Ba-Duan-Jin group and do not establish how the intervention worked.
The abstract supplies no between-group effect estimates, equivalence margin or adverse-event results. Similar reported improvements are insufficient to judge equivalence or comparative safety.
What researchers found
Sleep symptoms
Compared with pregabalin, sleep improvement was smaller at this assessment. The abstract gives no absolute sleep-score difference or confidence interval.
What the main comparison measured
Ba-Duan-Jin is a meditative movement practice. The trial's primary outcome was a pain rating, with other scales assessing common fibromyalgia symptoms. Single-blind means one party was unaware of assignment; the abstract does not identify whom.
Brain imaging was exploratory
Among adequate Ba-Duan-Jin responders, the researchers reported changes in a brain-imaging measure. Baseline imaging values also correlated with symptom improvement. These exploratory links do not demonstrate a brain mechanism or establish a reliable response predictor.
The original publication
Comparative efficacy of Ba-Duan-Jin and pregabalin in the treatment of fibromyalgia: An RCT with an exploratory analysis based on fMRI.
Li Y, Long M, Li Y et al.
J Pain · 2025
- PubMed ID
- 40615016
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.